Stock Chart
CVAC
Type: SELL wallstreet
Strike: $5
Premium: $0.40
Expiry: Apr 17, 2026
Target: $5
Score: -26
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About CVAC - CureVac N.V. Ordinary Shares
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
Key Statistics
More CVAC Analysis
This CVAC stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CVAC's price movements with trendlines, gamma walls, and key support/resistance levels.